• Home
  • -
  • specialty drugs

Uncategorized



Controlling New Specialty Drug Costs: Lessons from Farydak & Kalydeco

27 Sep, 2016 0.

In February 2015, the FDA approved Farydak, a new treatment for multiple myeloma. The drug’s wholesale price:  $6,860 for a 21 day cycle. But note that unless a health plan negotiates strong

The Frightening Implications of Farydak & Kalydeco

13 Jun, 2015 0.

In February 2015, the FDA approved Farydak, a new treatment for multiple myeloma. The drug’s wholesale price: $6,860 for a 21 day cycle. But note that unless a health plan